TQB3454 not checked
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Biliary Carcinoma, Advanced Solid Tumors
- Main trialPhase 3
- “This study used a randomized, controlled, double-blind, multicenter Phase III clinical design with overall survival (OS) as the primary endpoint. About 165 patients with advanced biliary carcinoma were enrolled and randomly assigned to the experimental group and the control group in a 2:1 ratio to receive TQB3454 tablets or the placebo, respectively, to evaluate the efficacy and safety of TQB3454 tablets in the treatment of advanced biliary carcinoma.”In the company’s words, NCT05987358 on ClinicalTrials.gov
Other drugs for Biliary Carcinoma
- AvelumabEMD Serono Research & Development Institute, Inc. · Phase 3
- Mirvetuximab SoravtansineAbbVie · Phase 3
- AzenosertibK-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Phase 3
- PembrolizumabMerck & Co. · Phase 3
- OregovomabCanariaBio Inc. · Phase 3
- JSKN003Alphamab · JMT-Bio · Phase 3
Coming up2
- DecPhase 3 trial completes · ClinicalTrials.gov
- Dec 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | Dec 2026 | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. | |
| Phase 2Not yet recruiting | Dec 2028 | Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors | |
| Phase 1/2Unknown | Jun 2025 | A Study of TQB3454 Tablets in Patients With Blood Tumors | |
| Phase 1Unknown | 31 Dec 2022 | A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets | |
| Phase 1Unknown | Dec 2023 | A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026